DK0654268T3 - Reversering af fænotypen af med transskriptionsfaktor IRF-1 transformerede celler - Google Patents

Reversering af fænotypen af med transskriptionsfaktor IRF-1 transformerede celler

Info

Publication number
DK0654268T3
DK0654268T3 DK94116044T DK94116044T DK0654268T3 DK 0654268 T3 DK0654268 T3 DK 0654268T3 DK 94116044 T DK94116044 T DK 94116044T DK 94116044 T DK94116044 T DK 94116044T DK 0654268 T3 DK0654268 T3 DK 0654268T3
Authority
DK
Denmark
Prior art keywords
phenotype
transformed cells
reversing
irf
transcription factor
Prior art date
Application number
DK94116044T
Other languages
Danish (da)
English (en)
Inventor
Taniguchi Tadatsugu
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Application granted granted Critical
Publication of DK0654268T3 publication Critical patent/DK0654268T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Tires In General (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Collating Specific Patterns (AREA)
DK94116044T 1993-10-19 1994-10-12 Reversering af fænotypen af med transskriptionsfaktor IRF-1 transformerede celler DK0654268T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP93116854A EP0648493A1 (de) 1993-10-19 1993-10-19 Verfahren zur Umkehrung des Phänotyps transformierter Zellen durch Transkriptionsfaktor IRF-1

Publications (1)

Publication Number Publication Date
DK0654268T3 true DK0654268T3 (da) 2002-03-11

Family

ID=8213351

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94116044T DK0654268T3 (da) 1993-10-19 1994-10-12 Reversering af fænotypen af med transskriptionsfaktor IRF-1 transformerede celler

Country Status (9)

Country Link
US (1) US5658774A (de)
EP (2) EP0648493A1 (de)
JP (1) JP3549266B2 (de)
AT (1) ATE211912T1 (de)
CA (1) CA2118373C (de)
DE (1) DE69429647T2 (de)
DK (1) DK0654268T3 (de)
ES (1) ES2170760T3 (de)
PT (1) PT654268E (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869040A (en) * 1995-06-07 1999-02-09 Biogen, Inc Gene therapy methods and compositions
US20030104356A1 (en) * 1999-11-22 2003-06-05 Smithkline Beecham Corporation Compounds and methods for treating and screening viral reactivation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0355190A1 (de) * 1988-08-24 1990-02-28 Tadatsugu Dr. Taniguchi Genexpression regulierender Faktor
ES2162801T3 (es) * 1988-08-24 2002-01-16 Tadatsugu Taniguchi Factor que regula la expresion genica.
NZ244306A (en) * 1991-09-30 1995-07-26 Boehringer Ingelheim Int Composition for introducing nucleic acid complexes into eucaryotic cells, complex containing nucleic acid and endosomolytic agent, peptide with endosomolytic domain and nucleic acid binding domain and preparation
IL103059A0 (en) * 1991-09-30 1993-02-21 Boehringer Ingelheim Int Conjugates for introducing nucleic acid into higher eucaryotic cells
MX9305855A (es) * 1992-09-24 1995-01-31 Tadatsugu Taniguchi Factores 1 y 2 reguladores del interferon en el diagnostico de latumorigenicidad.

Also Published As

Publication number Publication date
DE69429647T2 (de) 2002-08-14
PT654268E (pt) 2002-04-29
JPH07184654A (ja) 1995-07-25
EP0648493A1 (de) 1995-04-19
ATE211912T1 (de) 2002-02-15
DE69429647D1 (de) 2002-02-21
EP0654268B1 (de) 2002-01-16
ES2170760T3 (es) 2002-08-16
EP0654268A1 (de) 1995-05-24
US5658774A (en) 1997-08-19
CA2118373A1 (en) 1995-04-20
CA2118373C (en) 2008-09-23
JP3549266B2 (ja) 2004-08-04

Similar Documents

Publication Publication Date Title
NL990033I1 (nl) Tumornecrosefactor, werkwijzen om het te bereiden,samenstellingen die het bevatten, DNA dat ervoor codeert en proefmethoden met dergelijk DNA.
MY101852A (en) Tumor necrosis factor, methods for its preparation, containing it, dna encoding it and assay method using such dna.
DK1482046T3 (da) G-CSF analog sammensætninger og fremgangsmåder
NO985376L (no) Kinolinkarboksamider som TNF-inhibitorer og som PDA-IV inhibitorer
FI954966A (fi) Puutteellisia yhdistelmä-DNA-adenoviruksia kasvainten geeniterapiassa
DK453782A (da) Dna-sekvenser, rekombinant plasmid samt anvendelser deraf
DE3380848D1 (en) Molecular cloning of the gene for human anti-haemophilic factor ix
FI962114A (fi) Yhdistelmä-DNA-adenoviruksia syöpien geeniterapiaan
DE69433978D1 (de) Methode der spezifischen abschaltung von genen durch dna-methylierung
EP0722343A4 (de) Die behandlung von tumoren durch genetische transformation von tumorzellen mit genen, die für selektive, negative marker und für cytokine kodieren
DK0654268T3 (da) Reversering af fænotypen af med transskriptionsfaktor IRF-1 transformerede celler
IT1151625B (it) Trattamento enzimatico di vino e mosto
IT1237459B (it) Composizione di pigmento anticorrosiva per il trattamento.di superfici
DE69427290D1 (de) Verfahren zur induktion des todes von tumorzellen
DK1005532T3 (da) Isolerede nukleinsyremolekyler kodende for SSX familiemedlemmer og anvendelser deraf
NO950420L (no) Interferon endelse derav
DE68910036T2 (de) Luciferase-Gen und neue rekombinante DNA sowie Verfahren zur Herstellung von Luciferase.
IT8522355V0 (it) Proietto per bersagli morbidi e di durezza media.
CA2347371A1 (en) HEMATOPOIETIC REGULATION FACTORS AND METHODS OF USE
FR2696191B1 (fr) Acide nucléique codant pour une alpha-acétolactate décarboxylase et ses applications.
IT8821123A0 (it) Clonaggio del gene che codifica l'enzima isoamilasi e suo impiego per la produzione di detto enzima o suoi analoghi.
IT8821282A0 (it) Clonaggio del gene che codifica l'enzima isoamilasi e suo impiego per la produzione di detto enzima o suoi analoghi.
IT8621314A0 (it) Clonaggio e sequenziamento del frammento di dna che codifica per le cinque subunita' della tossina della pertosse, plasmide ibrido contenente detto frammento di dna e microorganismi trasformati con detto plasmide ibrido capaci di esprimere tutte o alcune delle subunita' della tossina della pertosse.
DE60023915D1 (de) Replikationsprotein-a-bindendes transkriptionsfaktor (rbt1) und dessen verwendungen